Entrada Therapeutics, Inc.
TRDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689375
In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Entrada Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 38 | −9 |
| Shares | 25.9M | 1.35K | 24.8M | −1.10M (−4.2%) |
| Value | $242.8M | $13.0K | $301.8M | +$59.0M (+24.3%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Entrada Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CHI Advisors LLC | 163,496 | $1.99M | 0.76% |
| Laurion Capital Management LP | 129,066 | $1.57M | 0.07% |
| Millennium Management LLC | 76,498 | $932.0K | 0.00% |
| Ergoteles LLC | 18,807 | $229.0K | 0.01% |
| Old Well Partners, LLC | 12,700 | $155.0K | 0.12% |
| Cubist Systematic Strategies, LLC | 1,874 | $23.0K | 0.00% |
| Advisor Group Holdings, Inc. | 300 | $4.00K | 0.00% |
| Credit Suisse AG | 6 | $0 | 0.00% |
Sold out (17)
Institutions that held Entrada Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Walleye Capital LLC | 44,652 | $419.0K |
| Bank of New York Mellon Corp | 21,933 | $206.0K |
| Ghisallo Capital Management LLC | 15,000 | $141.0K |
| Nuveen Asset Management, LLC | 13,872 | $130.0K |
| Renaissance Technologies LLC | 11,800 | $111.0K |
| American International Group, Inc. | 5,223 | $49.0K |
| Deutsche Bank AG | 4,959 | $47.0K |
| JPMorgan Chase & Co | 4,934 | $46.0K |
| California State Teachers Retirement System | 4,446 | $42.0K |
| Tower Research Capital LLC (TRC) | 2,485 | $23.0K |
| STRS Ohio | 2,100 | $19.0K |
| Amalgamated Bank | 1,350 | $13.0K |
| State of Wyoming | 1,060 | $10.0K |
| Legal & General Group Plc | 848 | $8.00K |
| Nisa Investment Advisors, LLC | 700 | $7.00K |
| Ameritas Investment Partners, Inc. | 708 | $7.00K |
| Royal Bank of Canada | 646 | $6.00K |
Not filed for Q2 2022 yet (1)
Institutions that held Entrada Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 1,350 | $13.0K |